SCM talks US demand for niche contracting at AAPS
SCM Pharma says demand for specialised contract manufacturing services is growing as the pharma industry focuses on niche indications, biologics and the development of potent medicines.
Archives for November 23, 2010
Appointments at Euthymics, CytomX, NPS Pharmaceuticals and InQ Biosciences – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Euthymics, CytomX, NPS Pharmaceuticals and InQ Biosciences.
Genzyme looks at bids based on Campath performance in MS
Rumours suggest that Genzyme would consider accepting lower value takeover bids that take into account future performance of its cancer drug Campath in MS indications.
Nose-to-brain delivery possible but challenges remain
Nose-to-brain delivery can become a reality, even for molecules with high molecular weights, but barriers relating to administration and adsorption remain, according to a panel at AAPS.
AAPS report
Millions of dollars wasted on failed recruitment
Poor recruitment practices cost the United States pharmaceutical industry millions of dollars, warns a leading US biopharma recruitment agency.
Dalton and Lonza offer bench to production chemistry services
Dalton Pharma Services and Lonza are teaming up to provide clients with a range of chemistry services, from discovery through to commercial production of active pharmaceutical ingredients (APIs).
Latin American sites recruit 91% more patients than US
Clinical trials in Latin America recruited 91 per cent more patients per site than studies conducted in the US from 2005 to 2009, according to EU MAA data.
J&J recall children’s Benadryl
Johnson & Johnson’s McNeil unit has initiated another recall, this time involving 4m packs of Children’s Benadryl allergy tablets and around 800,000 bottles of junior-strength Motrin caplets.